Effects of MT1 melatonin receptor overexpression on the aromatase-suppressive effect of melatonin in MCF-7 human breast cancer cells

Oncology Reports

Volumn 17, Issue 4, 2007, Pages 947-953

  Gonzalez A ^a   Martinez Campa C ^a   Mediavilla, M D ^a   Alonso Gonzalez C ^a   Sanchez Mateos S ^a   Hill, S M ^b   Sanchez Barcelo E J ^a   Cos, Samuel ^a  

^a UNIVERSITY OF CANTABRIA   (Spain)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aromatase; Breast cancer; MCF 7 cells; Melatonin; Pineal

Indexed keywords

ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; AROMATASE; DIAGNOSTIC AGENT; MELATONIN; MELATONIN 1 RECEPTOR; MESSENGER RNA;

ARTICLE; BREAST TUMOR; CELL PROLIFERATION; DOWN REGULATION; DRUG EFFECT; ENZYMOLOGY; GENETICS; HUMAN; METABOLISM; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS, HORMONAL; AROMATASE; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; HUMANS; MELATONIN; RECEPTOR, MELATONIN, MT1; RNA, MESSENGER;

EID: 34249946558     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.17.4.947     Document Type: Article

References (28)

1. Russo IH and Russo J: Role of hormones in mammary cancer initiation and progression. J Mammary Gland Biol Neoplasia 3: 49-61, 1998. (Pubitemid 128513219)
2. Cos S and Sánchez-Barceló EJ: Melatonin and mammary pathological growth. Front Neuroendocrinol 21: 133-170, 2000. (Pubitemid 30228502)
3. Cos S and Sánchez-Barceló EJ: Melatonin, experimental basis for a possible application in breast cancer prevention and treatment. Histol Histopathol 15: 637-647, 2000. (Pubitemid 30218860)
4. Blask DE, Sauer LA and Dauchy RT: Melatonin as a chronobiotic/anticancer agent: cellular, biochemical and molecular mechanisms of action and their implications for circadian-based cancer therapy. Curr Topics Med Chem 2: 113-132, 2002.
5. Sánchez-Barceló EJ, Cos S, Fernández R and Mediavilla MD: Melatonin and mammary cancer: a short review. Endocr Relat Cancer 10: 153-159, 2003. (Pubitemid 36758644)
6. Sánchez-Barceló EJ, Cos S, Mediavilla MD, Martínez-Campa C, González A and Alonso-González C: Melatonin-estrogen interactions in breast cancer. J Pineal Res 38: 217-222, 2005.
7. Zhou D, Wang J, Chen E, Murai J, Siiteri PK and Chen S: Aromatase gene is amplified in MCF-7 human breast cancer cells. J Steroid Biochem Mol Biol 46: 147-153, 1993. (Pubitemid 23251672)
8. Sonne-Hansen K and Lykkesfeldt AE: Endogenous aromatization of testosterone results in growth stimulation of the human MCF-7 breast cancer cell line. J Steroid Biochem Mol Biol 93: 25-34, 2005. (Pubitemid 40312730)
9. Ram PT, Dai J, Yuan L, Dong C, Kiefer TL, Lai L and Hill SM: Involvement of the MT-1 melatonin receptor in human breast cancer. Cancer Lett 179: 141-150, 2002. (Pubitemid 34215105)
10. Ram PT, Kiefer T, Silverman M, Song Y, Brown GM and Hill SM: Estrogen receptor transactivation in MCF-7 breast cancer cells by melatonin and growth factors. Mol Cell Endocrinol 141: 53-64, 1998. (Pubitemid 28393379)
11. Cos S, Martínez-Campa C, Mediavilla MD and Sánchez- Barceló EJ: Melatonin modulates aromatase activity in MCF-7 human breast cancer cells. J Pineal Res 38: 136-142, 2005. (Pubitemid 40293239)
12. Cos S, González A, Güezmes A, Mediavilla MD, Martínez-Campa C, Alonso-González C and Sánchez- Barceló EJ: Melatonin inhibits the growth of DMBA-induced mammary tumors by decreasing the local biosynthesis of estrogens through the modulation of aromatase activity. Int J Cancer 118: 274-278, 2006. (Pubitemid 41779064)
13. Vanecek J: Cellular mechanisms of melatonin action. Physiol Rev 78: 687-721, 1998.
14. Becker-Andre M, Wiesenberg I, Schaeren-Wiemers N, Andre E, Missbach M, Saurat JH and Carlberg C: Pineal gland hormone melatonin binds and activates an orphan of the nuclear receptor superfamily. J Biol Chem 269: 28531-28534, 1994. (Pubitemid 24366678)
15. Kiefer T, Ram PT, Yuan L and Hill SM: Melatonin inhibits estrogen receptor transactivation and cAMP levels in breast cancer cells. Breast Cancer Res Treat 71: 37-45, 2002. (Pubitemid 34121815)
16. 2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) gene. Endocrinology 137: 5739-5742, 1996.
17. Zhou D, Clarke P, Wang J and Chen S: Identification of a promoter that controls aromatase expression in human breast cancer and adipose stromal cells. J Biol Chem 271: 15194-15202, 1996. (Pubitemid 26195000)
18. Bulun SE, Sebastian S, Takayama K, Suzuki T, Sasano H and Shozu M: The human CYP19 (aromatase P450) gene: update on physiologic roles and genomic organization of promoters. J Steroid Biochem Mol Biol 86: 219-224, 2003. (Pubitemid 37412560)
19. 1 melatonin receptor overexpression enhances the growth suppressive effect of melatonin in human breast cancer cells. Mol Cell Endocrinol 192: 147-156, 2002.
20. Reppert SM, Weaver DR and Ebisawa T: Cloning and characterization of a melatonin receptor that mediates reproductive and circadian responses. Neuron 13: 1177-1185, 1994. (Pubitemid 24372135)
21. Collins A, Yuan L, Kiefer TL, Cheng Q, Lai L and Hill SM: Overexpresssion of the MT1 melatonin receptor in MCF-7 human breast cancer cells inhibits mammary tumor formation in nude mice. Cancer Lett 189: 49-57, 2003. (Pubitemid 35351519)
22. Zava DT and McGuire WL: Androgen action through estrogen receptor in a human breast cancer cell line. Endocrinology 103: 624-631, 1978. (Pubitemid 8393745)
23. Burak WE, Quinn AL, Farrar WB and Brueggemeier RW: Androgens influence estrogen-induced responses in human breast carcinoma cells through cytochrome P450 aromatase. Breast Cancer Res Treat 44: 57-64, 1997. (Pubitemid 27179769)
24. Ackerman GE, Smith ME, Mendelson CR, MacDonald PC and Simpson ER: Aromatization of androstenedione by human adipose tissue stromal cells in monolayer culture. J Clin Endocrinol Metab 53: 412-417, 1981. (Pubitemid 13250304)
25. Cos S, Garijo F, Corral J, Mediavilla MD and Sánchez- Barceló EJ: Histopathologic features of DMBA-induced mammary tumors in blind-underfed, blind-anosmic, and blind cold-exposed rats: influence of the pineal gland. J Pineal Res 6: 221-231, 1989. (Pubitemid 19061913)
26. Cos S, Fernández R, Güezmes A and Sánchez- Barceló EJ: Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells. Cancer Res 58: 4383-4390, 1998. (Pubitemid 28450041)
27. Ram PT, Yuan L, Dai J, Kiefer T, Klotz DM, Spriggs LL and Hill SM: Differential responsiveness of MCF-7 human breast cancer cell line stocks to the pineal hormone, melatonin. J Pineal Res 28: 210-218, 2000. (Pubitemid 30255373)
28. 1a-melatonin receptor and Gi: precoupling and constitutive activity. Mol Pharmacol 56: 1014-1024, 1999.